<DOC>
	<DOCNO>NCT00819104</DOCNO>
	<brief_summary>This randomise , open-label ; parallel group , multicentric study compare efficacy safety fixed-dose-combinations Metoprolol XL plus Amlodipine individual component combination . SelomaxTM50/5 also compare SelomaxTM 25/2.5 lower BP ( SBP DBP ) Indian patient essential hypertension.Male female patient essential hypertension age 18-80 year study . The patient history prior cardiovascular disease .</brief_summary>
	<brief_title>A Study Compare Efficacy , Safety Tolerability Selomax With Its Individual Components</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Patients hypertension ( primary ) , judge 2 BP measurement randomisation Those give write consent study . Patients forms hypertension ( primary ) Those consistently BP &gt; /=180/120mmHg Patients prior history chest pain , heart attack , conduction defect stroke . Patients diabetes require insulin , asthma kidney disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Primary hypertension</keyword>
	<keyword>Metoprolol XL</keyword>
	<keyword>Amlodipine</keyword>
</DOC>